Recent Advances in Biomarkers for Cardiovascular Disease
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 70
Special Issue Editor
Interests: cardiovascular diseases; metabolic diseases; diabetes mellitus; antioxidants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular disease is still the leading cause of morbidity and mortality worldwide despite the great diagnostic and therapeutic progress made in recent decades. Intervention using cardiovascular risk factors is seen as the best long-term solution to improve the outcome of these patients. Therefore, their identification and appropriate therapeutic approach are of the utmost importance.
Some of them are behavioral risk factors, such as unhealthy diet, physical inactivity, tobacco use, and excessive alcohol consumption. Although it is not difficult to correct them, their prevalence remains high because the population is not fully aware of their harmful effect on health. The continuous and long-term action of behavioral risk factors is associated with overweight and obesity, atherogenic dyslipidemia, diabetes, and hypertension, all of which are strong risk factors for cardiovascular disease. The risk of stroke, ischemic heart disease, peripheral artery disease, heart failure, and death that an individual has increases exponentially as risk factors accumulate because they potentiate each other and accelerate target organ damage.
Although there are many different risk factors that increase the likelihood of developing cardiovascular disease, they are largely preventable. By implementing a healthy lifestyle and appropriate pharmacological intervention, we can improve the longevity and quality of life of millions of people around the world.
We invite you to share your knowledge and experience by contributing to this Special Issue. Original and review papers that address cardiovascular risk factors in all aspects, from cellular and molecular mechanisms, and pathophysiological links to problems of diagnosis, treatment, and monitoring, are welcome. We look forward to receiving your contributions.
Dr. Manuela Ciocoiu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular risk factors
- hypertension
- dyslipidemia
- overweight
- obesity
- diabetes mellitus
- metabolic syndrome
- atherosclerosis
- physical inactivity
- biomarkers
- cardiovascular disease
